Patents by Inventor Guenther Grabner

Guenther Grabner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10842671
    Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques. A method for treating glaucoma can include positioning an intraocular shunt in eye tissue such that the shunt conducts fluid from the anterior chamber to the suprachoroidal space and delivers a pharmaceutical or biological agent to the eye.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: November 24, 2020
    Assignee: AqueSys, Inc.
    Inventors: Christopher Horvath, Ronald D. Bache, Laszlo O. Romoda, Guenther Grabner, Herbert A. Reitsamer, John R. Samples
  • Publication number: 20190240069
    Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques. A method of treating glaucoma can be performed by a clinician, in which a hollow needle is inserted into an eye through the sclera. The hollow needle can carry an intraocular shunt. Once inserted and properly positioned, the clinician can release the shunt from the needle such that the shunt conducts fluid away from the anterior chamber of the eye.
    Type: Application
    Filed: April 17, 2019
    Publication date: August 8, 2019
    Inventors: Christopher HORVATH, Laszlo O. ROMODA, Guenther GRABNER, Herbert A. REITSAMER
  • Publication number: 20190167475
    Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.
    Type: Application
    Filed: February 4, 2019
    Publication date: June 6, 2019
    Inventors: Christopher HORVATH, Laszlo O. ROMODA, Brian HAMSTROM, Ronald D. BACHE, Guenther GRABNER, Herbert A. REITSAMER
  • Patent number: 10195079
    Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: February 5, 2019
    Assignee: AqueSys, Inc.
    Inventors: Christopher Horvath, Laszlo O. Romoda, Brian Hamstrom, Ronald D. Bache, Guenther Grabner, Herbert A. Reitsamer
  • Patent number: 10195078
    Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: February 5, 2019
    Assignee: AqueSys, Inc.
    Inventors: Christopher Horvath, Laszlo O. Romoda, Brian Hamstrom, Ronald D. Bache, Guenther Grabner, Herbert A. Reitsamer
  • Patent number: 10159600
    Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.
    Type: Grant
    Filed: February 19, 2013
    Date of Patent: December 25, 2018
    Assignee: AqueSys, Inc.
    Inventors: Christopher Horvath, Laszlo O. Romoda, Brian Hamstrom, Ronald D. Bache, Guenther Grabner, Herbert A. Reitsamer
  • Patent number: 10085884
    Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: October 2, 2018
    Assignee: AQUESYS, INC.
    Inventors: Herbert A. Reitsamer, Guenther Grabner, Christopher Horvath, Laszlo O. Romoda
  • Publication number: 20160256322
    Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.
    Type: Application
    Filed: May 17, 2016
    Publication date: September 8, 2016
    Inventors: Christopher HORVATH, Laszlo O. ROMODA, Brian HAMSTROM, Ronald D. BACHE, Guenther GRABNER, Herbert A. REITSAMER
  • Publication number: 20160256317
    Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques. A method for treating glaucoma can include positioning an intraocular shunt in eye tissue, without use of an optical apparatus that contacts the eye, such that the shunt conducts fluid from the anterior chamber of the eye and delivers a pharmaceutical or biological agent to the eye.
    Type: Application
    Filed: May 12, 2016
    Publication date: September 8, 2016
    Inventors: Christopher HORVATH, Laszlo O. ROMODA, Guenther GRABNER, Herbert A. REITSAMER
  • Publication number: 20160256319
    Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques. A method for treating glaucoma can include positioning an intraocular shunt in eye tissue such that the shunt conducts fluid from the anterior chamber to the suprachoroidal space and delivers a pharmaceutical or biological agent to the eye.
    Type: Application
    Filed: May 12, 2016
    Publication date: September 8, 2016
    Inventors: Christopher HORVATH, Ronald D. BACHE, Laszlo O. ROMODA, Guenther GRABNER, Herbert A. REITSAMER, John R. SAMPLES
  • Publication number: 20160256318
    Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques. A method for treating glaucoma can include positioning an intraocular shunt in eye tissue such that the shunt conducts fluid from the anterior chamber to the suprachoroidal space and delivers a pharmaceutical or biological agent to the eye.
    Type: Application
    Filed: May 12, 2016
    Publication date: September 8, 2016
    Inventors: Christopher HORVATH, Ronald D. BACHE, Laszlo O. ROMODA, Guenther GRABNER, Herbert A. REITSAMER, John R. SAMPLES
  • Publication number: 20160256321
    Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.
    Type: Application
    Filed: May 16, 2016
    Publication date: September 8, 2016
    Inventors: Christopher HORVATH, Laszlo O. ROMODA, Brian HAMSTROM, Ronald D. BACHE, Guenther GRABNER, Herbert A. REITSAMER
  • Publication number: 20160256320
    Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques. A method for treating glaucoma can include injecting a drug into the eye and positioning an intraocular shunt in eye tissue such that the shunt conducts fluid from the anterior chamber to the suprachoroidal space.
    Type: Application
    Filed: May 12, 2016
    Publication date: September 8, 2016
    Inventors: Christopher HORVATH, Ronald D. BACHE, Laszlo O. ROMODA, Guenther GRABNER, Herbert A. REITSAMER, John R. SAMPLES
  • Patent number: 9326891
    Abstract: The present invention generally relates to methods for deploying intraocular shunts without the use of an optical apparatus that contacts an eye, such as a goniolens. In certain embodiments, methods of the invention involve inserting into an eye a deployment device configured to hold an intraocular shunt, determining that a distal portion of the device is properly positioned within the eye without use of an optical apparatus that contacts the eye, and deploying the shunt from the device.
    Type: Grant
    Filed: May 15, 2013
    Date of Patent: May 3, 2016
    Assignee: AqueSys, Inc.
    Inventors: Christopher Horvath, Laszlo O. Romoda, Guenther Grabner, Herbert A. Reitsamer
  • Patent number: 9125723
    Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.
    Type: Grant
    Filed: February 19, 2013
    Date of Patent: September 8, 2015
    Assignee: AqueSys, Inc.
    Inventors: Christopher Horvath, Laszlo O. Romoda, Brian Hamstrom, Ronald D. Bache, Guenther Grabner, Herbert A. Reitsamer
  • Patent number: 9095411
    Abstract: The present invention generally relates to devices for deploying intraocular shunts without the use of an optical apparatus that contacts an eye, such as a goniolens. In certain embodiments, devices of the invention include a housing including a proximal portion and a distal portion, in which the distal portion is movable within the proximal portion, a deployment mechanism at least partially disposed within the housing, and a hollow shaft coupled to the deployment mechanism, in which the shaft is configured to hold an intraocular shunt.
    Type: Grant
    Filed: November 15, 2010
    Date of Patent: August 4, 2015
    Assignee: AqueSys, Inc.
    Inventors: Christopher Horvath, Laszlo O. Romoda, Guenther Grabner, Herbert A. Reitsamer
  • Publication number: 20150011926
    Abstract: Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques.
    Type: Application
    Filed: June 24, 2014
    Publication date: January 8, 2015
    Inventors: Herbert A. Reitsamer, Guenther Grabner, Christopher Horvath, Laszlo O. Romoda
  • Patent number: 8852137
    Abstract: The invention generally relates to methods for implanting a soft gel shunt in the suprachoroidal space. In certain embodiments, methods of the invention involve inserting into the eye a hollow shaft configured to hold a soft gel intraocular shunt, deploying the soft gel shunt from the hollow shaft such that the shunt forms a passage from the anterior chamber of the eye to the suprachoroidal space of the eye, and withdrawing the hollow shaft from the eye.
    Type: Grant
    Filed: December 23, 2011
    Date of Patent: October 7, 2014
    Assignee: AqueSys, Inc.
    Inventors: Christopher Horvath, Ronald D. Bache, Laszlo O. Romoda, Guenther Grabner, Herbert A. Reitsamer, John R. Samples
  • Patent number: 8828070
    Abstract: The present invention generally relates to devices for deploying intraocular shunts without the use of an optical apparatus that contacts an eye, such as a goniolens. In certain embodiments, devices of the invention include a housing, in which a distal end of the housing includes a protrusion, a deployment mechanism at least partially disposed within the housing, and a hollow shaft coupled to the deployment mechanism, in which the shaft is configured to hold an intraocular shunt.
    Type: Grant
    Filed: November 15, 2010
    Date of Patent: September 9, 2014
    Assignee: AqueSys, Inc.
    Inventors: Laszlo O. Romoda, Christopher Horvath, Guenther Grabner, Herbert A. Reitsamer
  • Publication number: 20140236067
    Abstract: Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.
    Type: Application
    Filed: February 19, 2013
    Publication date: August 21, 2014
    Applicant: AQUESYS, INC.
    Inventors: Christopher HORVATH, Laszlo O. ROMODA, Brian HAMSTROM, Ronald D. BACHE, Guenther GRABNER, Herbert A. REITSAMER